195 related articles for article (PubMed ID: 2610686)
1. Sphingolipid hydrolase activator proteins and their precursors.
Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
3. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
4. Saposins: structure, function, distribution, and molecular genetics.
Kishimoto Y; Hiraiwa M; O'Brien JS
J Lipid Res; 1992 Sep; 33(9):1255-67. PubMed ID: 1402395
[TBL] [Abstract][Full Text] [Related]
5. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
7. Distribution of prosaposin-like immunoreactivity in rat brain.
Kondoh K; Sano A; Kakimoto Y; Matsuda S; Sakanaka M
J Comp Neurol; 1993 Aug; 334(4):590-602. PubMed ID: 8408767
[TBL] [Abstract][Full Text] [Related]
8. Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.
Tayama M; O'Brien JS; Kishimoto Y
J Mol Neurosci; 1992; 3(4):171-5. PubMed ID: 1389998
[TBL] [Abstract][Full Text] [Related]
9. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
10. Determination of saposin proteins (sphingolipid activator proteins) in human tissues.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157
[TBL] [Abstract][Full Text] [Related]
11. Secretion of sphingolipid hydrolase activator precursor, prosaposin.
Hineno T; Sano A; Kondoh K; Ueno S; Kakimoto Y; Yoshida K
Biochem Biophys Res Commun; 1991 Apr; 176(2):668-74. PubMed ID: 2025281
[TBL] [Abstract][Full Text] [Related]
12. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
[TBL] [Abstract][Full Text] [Related]
13. Binding of cerebrosides and sulfatides to saposins A-D.
Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of acid ceramidase activity by saposin D.
Azuma N; O'Brien JS; Moser HW; Kishimoto Y
Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
16. Saposin proteins: structure, function, and role in human lysosomal storage disorders.
O'Brien JS; Kishimoto Y
FASEB J; 1991 Mar; 5(3):301-8. PubMed ID: 2001789
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for lysosomal targeting of the prosaposin precursor protein.
Ham D
Cell Biol Int; 2003; 27(8):675-87. PubMed ID: 12867159
[TBL] [Abstract][Full Text] [Related]
18. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y
Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278
[TBL] [Abstract][Full Text] [Related]
19. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
20. Identification of prosaposin as a neurotrophic factor.
O'Brien JS; Carson GS; Seo HC; Hiraiwa M; Kishimoto Y
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9593-6. PubMed ID: 7937812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
